Literature DB >> 25664022

Age at first birth and melanoma risk: a meta-analysis.

Zhengyong Li1, Mingjin Gu2, Ying Cen1.   

Abstract

Age at first birth has been shown to be correlated with melanoma risk, but the results were inconsistent. Thus, a meta-analysis was undertaken to evaluate the relationship between age at first birth and melanoma risk. Studies published up to September 6, 2014 were identified through searches of PubMed and EMBASE databases. Random-effect model was used to pool the study-specific risk estimates (RRs) with 95% confidence intervals (CIs). Three case-control, three nested case-control, and five cohort studies were found to be eligible. In a comparison of the oldest versus youngest age at first birth, the pooled RR for melanoma risk was 1.47 (95% CI: 1.07-2.02) in all studies, 1.37 (95% CI: 0.47-4.02) in population-based case-control studies, 2.69 (95% CI: 1.56-4.64) in hospital case-control studies, 1.38 (95% CI: 0.66-2.88) in nested case-control studies, and 1.39 (95% CI: 0.89-2.17) in cohort studies. In the subgroup analysis according to sites where studies were performed, the pooled RR was 1.44 (95% CI: 0.99-2.08), 1.18 (95% CI: 0.30-4.60), and 2.36 (95% CI: 1.42-3.93) for Europe, Americas, and Australia, respectively. In the subgroup stratified by whether the included study provided adjustment for specific potential confounders or important risk factors, the relationship between age at first birth and melanoma risk was significantly modified by age, naevi/pigmentation, sunlight exposure, and hair colour. This meta-analysis based on available observational data reveals that age at first birth is positively associated with melanoma risk. However, this finding should be interpreted cautiously, as residual confounding cannot be excluded. More investigations with well-designed are warranted to extend this finding.

Entities:  

Keywords:  Melanoma; birth; hormone; meta-analysis; reproductive history

Year:  2014        PMID: 25664022      PMCID: PMC4307469     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  59 in total

1.  Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies.

Authors:  Esteve Fernandez; Silvano Gallus; Cristina Bosetti; Silvia Franceschi; Eva Negri; Carlo La Vecchia
Journal:  Int J Cancer       Date:  2003-06-20       Impact factor: 7.396

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  Pregnancy history and incidence of melanoma in women: a pooled analysis.

Authors:  Margaret R Karagas; Michael S Zens; Therese A Stukel; Anthony J Swerdlow; Stefano Rosso; Anne Osterlind; Thomas Mack; Connie Kirkpatrick; Elizabeth A Holly; Adele Green; Richard Gallagher; J Mark Elwood; Bruce K Armstrong
Journal:  Cancer Causes Control       Date:  2006-02       Impact factor: 2.506

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  Do hormones influence melanoma? Facts and controversies.

Authors:  Amie Gupta; Marcia S Driscoll
Journal:  Clin Dermatol       Date:  2010 May-Jun       Impact factor: 3.541

6.  Oral contraceptive use and malignant melanoma.

Authors:  C Bain; C H Hennekens; F E Speizer; B Rosner; W Willett; C Belanger
Journal:  J Natl Cancer Inst       Date:  1982-04       Impact factor: 13.506

7.  Hormonal and reproductive influences and risk of melanoma in women.

Authors:  M A Smith; J A Fine; R L Barnhill; M Berwick
Journal:  Int J Epidemiol       Date:  1998-10       Impact factor: 7.196

8.  Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.

Authors:  G Corrao; A Zambon; V Conti; F Nicotra; C La Vecchia; C Fornari; G Cesana; P Contiero; G Tagliabue; R E Nappi; L Merlino
Journal:  Ann Oncol       Date:  2007-09-04       Impact factor: 32.976

9.  Hormonal factors and melanoma in women.

Authors:  A Green; C Bain
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

10.  Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004.

Authors:  M Vessey; R Painter
Journal:  Br J Cancer       Date:  2006-07-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.